U.S. FDA Approves ABRYSVO™, Pfizer's Vaccine for the Prevention of Respiratory Syncytial Virus (RSV) in Infants Through Active Immunization of Pregnant Individuals 32-36 Weeks of Gestational AgeBusiness Wire • 08/21/23
The 3 Most Undervalued Dividend Stocks With Growth Potential to Buy Now: August 2023InvestorPlace • 08/20/23
New Covid vaccines from Pfizer, Moderna and Novavax will likely protect against Eris variantCNBC • 08/18/23
Covid Vaccine Rally Dashed As Pfizer, Moderna Give Back Gains On Eris' AdvanceInvestors Business Daily • 08/18/23
Here's Why Pfizer's High-Yield Dividend Could Be Even Safer Than You Might ThinkThe Motley Fool • 08/15/23